| Primary |
| Renal Failure Chronic |
32.3% |
| Product Used For Unknown Indication |
13.6% |
| Anaemia |
11.4% |
| Anaemia Of Malignant Disease |
9.1% |
| Dialysis |
9.0% |
| Drug Use For Unknown Indication |
7.1% |
| Nephrogenic Anaemia |
5.1% |
| Myelodysplastic Syndrome |
4.9% |
| Hypertension |
1.5% |
| Renal Transplant |
1.3% |
| Chemotherapy |
0.7% |
| Renal Failure |
0.7% |
| Hyperparathyroidism Secondary |
0.6% |
| Diabetes Mellitus |
0.6% |
| Hepatitis C |
0.5% |
| Multiple Myeloma |
0.4% |
| Prophylaxis |
0.3% |
| Hyperphosphataemia |
0.3% |
| Renal Hypertension |
0.3% |
| Hypercholesterolaemia |
0.2% |
|
| Death |
19.2% |
| Therapeutic Response Decreased |
19.1% |
| Aplasia Pure Red Cell |
16.1% |
| Haemoglobin Decreased |
9.6% |
| Drug Ineffective |
5.6% |
| Anaemia |
3.8% |
| Hospitalisation |
3.4% |
| Injection Site Pain |
2.7% |
| Thrombocytopenia |
2.2% |
| Vomiting |
2.1% |
| Myelodysplastic Syndrome |
2.1% |
| Urticaria |
1.9% |
| Pyrexia |
1.7% |
| Weight Decreased |
1.7% |
| Malaise |
1.6% |
| Rash |
1.5% |
| Myocardial Infarction |
1.5% |
| Thrombosis |
1.4% |
| Pain |
1.4% |
| Renal Failure |
1.3% |
|
| Secondary |
| Product Used For Unknown Indication |
15.9% |
| Renal Failure Chronic |
15.6% |
| Anaemia |
13.2% |
| Drug Use For Unknown Indication |
11.2% |
| Dialysis |
7.5% |
| Nephrogenic Anaemia |
6.5% |
| Anaemia Of Malignant Disease |
5.2% |
| Myelodysplastic Syndrome |
3.9% |
| Hypertension |
2.8% |
| Multiple Myeloma |
2.5% |
| Chemotherapy |
2.4% |
| Renal Failure |
1.9% |
| Breast Cancer |
1.8% |
| Hepatitis C |
1.6% |
| Breast Cancer Metastatic |
1.5% |
| Hyperparathyroidism Secondary |
1.5% |
| Lymphoma |
1.4% |
| Diabetes Mellitus |
1.4% |
| Renal Transplant |
1.3% |
| Prophylaxis |
1.1% |
|
| Aplasia Pure Red Cell |
23.8% |
| Therapeutic Response Decreased |
15.4% |
| Drug Ineffective |
8.2% |
| Death |
7.1% |
| Haemoglobin Decreased |
5.2% |
| Anaemia |
4.9% |
| Vomiting |
4.7% |
| Thrombocytopenia |
3.6% |
| Pulmonary Embolism |
3.2% |
| Renal Transplant |
3.2% |
| Fatigue |
2.8% |
| Weight Decreased |
2.8% |
| Gastrointestinal Telangiectasia |
2.3% |
| Rash |
2.1% |
| Renal Failure |
2.1% |
| Stillbirth |
2.1% |
| Pyrexia |
1.8% |
| Asthenia |
1.6% |
| Neuropathy Peripheral |
1.6% |
| Pancytopenia |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.8% |
| Drug Use For Unknown Indication |
24.0% |
| Multiple Myeloma |
6.9% |
| Hypertension |
5.1% |
| Anaemia |
4.4% |
| Pain |
4.4% |
| Prophylaxis |
3.2% |
| Nuclear Magnetic Resonance Imaging |
3.0% |
| Breast Cancer |
2.6% |
| Renal Transplant |
1.8% |
| Diabetes Mellitus |
1.5% |
| Metastases To Bone |
1.5% |
| Angiogram |
1.4% |
| Non-small Cell Lung Cancer |
1.3% |
| Hyperparathyroidism Secondary |
1.2% |
| Myelodysplastic Syndrome |
1.2% |
| Infection Prophylaxis |
1.2% |
| Prophylaxis Against Transplant Rejection |
1.2% |
| Nausea |
1.1% |
| Anxiety |
1.1% |
|
| Vomiting |
16.8% |
| Weight Decreased |
9.7% |
| White Blood Cell Count Decreased |
7.2% |
| Thrombocytopenia |
6.9% |
| Pyrexia |
5.3% |
| Death |
5.0% |
| Sepsis |
4.5% |
| Weight Increased |
4.4% |
| Renal Failure |
4.2% |
| Urinary Tract Infection |
4.1% |
| Pneumonia |
3.9% |
| Renal Failure Acute |
3.6% |
| Syncope |
3.6% |
| Pancytopenia |
3.2% |
| Tooth Extraction |
3.2% |
| Wound Drainage |
3.1% |
| Skin Tightness |
3.0% |
| Anaemia |
2.8% |
| Wheezing |
2.8% |
| White Blood Cell Count Increased |
2.7% |
|
